Monitoring the Microbiome in Leukemia Patients Could Reduce Infections During Chemotherapy

Explore how monitoring the microbiome in leukemia patients could reduce infections during chemotherapy in this 39-minute talk by Dr. Jessica Galloway-Peña. Learn about the link between microbial diversity and infection risk during induction chemotherapy, the impact of illness and therapeutics on the microbiome, and the potential consequences for immunocompromised cancer patients. Discover insights on beta diversity, risk stratification, good and bad bacteria, viral infections, and the cost of sequencing. Examine observations on predicting infections, the relationship between the microbiome and chemotherapy, common infections in leukemia patients, and the potential of fecal transplantation. Gain understanding of how leukemia and chemotherapy affect the microbiome, and explore relevant mouse models in this informative presentation from the American Society for Microbiology.

Intro
Welcome
The Microbiome
Induction Chemotherapy
Antibiotics
Characterization
Beta Diversity
Risk stratifying
Good bacteria and bad bacteria
Understanding the microbiome
Viral infections
Cost of sequencing
Exome sequencing
Cost
Predicting Infection
Observations
Microbiome and Chemotherapy
Most Common Infections
UTIs
Food
Fecal transplantation
Does a leukemia patient have a different microbiome
Chemotherapy and the microbiome
The mouse model
Outro